What does Cancer Research Institute do?

The Cancer Research Institute (CRI) is a nonprofit organization based in New York City, established in 1953. Its primary focus is on funding research in cancer immunology and immunotherapy to develop new treatments for various types of cancer. Since its inception, CRI has awarded over $500 million in grants to more than 3,000 scientists globally, supporting the advancement of cancer treatment. CRI plays a pivotal role in the field of tumor immunology, having pioneered immunotherapy as a key component of cancer treatment. The organization funds research at leading academic institutions and coordinates an international network of scientists. It also hosts conferences and provides educational resources on immune therapies. Notable achievements include significant contributions to the development of checkpoint inhibitors and the discovery of the PD-1 pathway, which have led to FDA-approved therapies. Under the leadership of CEO Alicia Zhou, CRI continues to integrate data science and innovative technologies to enhance cancer treatment options.